ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)
Tuesday, February 16th, 2010ExonHit Therapeutics hopes to commercialize a microarray-based clinical test for diagnosing Alzheimer’s disease in Europe by the first quarter of next year, the company said this week.
More:
ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)